Yumanity Therapeutics reported the appointment of Patricia Allen to its Board of Directors and chairperson of the Audit Committee. According to a media release, Allen has more than 25 years of financial leadership experience in the biotechnology industry. She has been critical to the growth of several leading publicly-traded and privately-held companies. Allen currently serves as chief financial officer of Zafgen Inc., where she leads all aspects of finance, investor relations, communications, human resources, information technology, as well as facilities management and operations.